Johnson & Johnson (JNJ): 2024 Challenges, 2025 OpportunitiesJohnson & Johnson could become one of the standout plays for 2025 if key levels are respected.
A Brief Recap of NYSE:JNJ in 2024
Johnson & Johnson experienced a challenging year. The company finalized the spin-off of its Consumer Health division, sharpening its focus on Pharmaceuticals and MedT